Powell Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$628K Hold
683
0.22% 68
2025
Q4
$734K Hold
683
0.25% 62
2025
Q3
$521K Hold
683
0.18% 79
2025
Q2
$532K Hold
683
0.2% 71
2025
Q1
$564K Hold
683
0.28% 56
2024
Q4
$527K Hold
683
0.24% 63
2024
Q3
$605K Buy
683
+20
+3% +$18K 0.28% 53
2024
Q2
$600K Buy
663
+24
+4% +$19.2K 0.31% 49
2024
Q1
$497K Hold
639
0.26% 62
2023
Q4
$372K Buy
639
+20
+3% +$11.7K 0.21% 74
2023
Q3
$332K Hold
619
0.2% 78
2023
Q2
$290K Hold
619
0.17% 82
2023
Q1
$213K Hold
619
0.12% 96
2022
Q4
$226K Sell
619
-241
-28% -$85.4K 0.13% 94
2022
Q3
$278K Hold
860
0.18% 89
2022
Q2
$279K Hold
860
0.17% 85
2022
Q1
$246K Buy
860
+12
+1% +$3.09K 0.14% 87
2021
Q4
$234K Buy
+848
New +$215K 0.13% 93

Other funds holding LLY

Powell Investment Advisors's LLY Position: Q1 2026 in Review

Powell Investment Advisors held its Eli Lilly (LLY) position steady in Q1 2026 at 683 shares worth $628K. The position accounts for 0.22% of the portfolio, ranked #68.

Powell Investment Advisors first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $734K in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Powell Investment Advisors held 683 shares of Eli Lilly worth $628K as of Q1 2026.
  • Powell Investment Advisors left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.22% of Powell Investment Advisors's portfolio in Q1 2026, its #68 holding.
  • Powell Investment Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • Powell Investment Advisors's Eli Lilly position peaked at $734K in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Powell Investment Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.